TuHURA Biosciences, Inc. (HURA) vs Insight Molecular Diagnostics Inc. (IMDX)
A side-by-side comparison of TuHURA Biosciences, Inc. and Insight Molecular Diagnostics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
HURA
TuHURA Biosciences, Inc.
$1.88HealthcareDelayed quote: Oct 6, 2026, 10:40 AM EDT
IMDX
Insight Molecular Diagnostics Inc.
$3.63HealthcareDelayed quote: Oct 6, 2026, 10:40 AM EDT
Total return — HURA vs IMDX
growth of $100 · dividends reinvested · last 10yHURA -99.9% (-52.1%/yr)IMDX -96.4% (-28.2%/yr)IMDX compounded faster over this window
Log scale — wide-divergence pair
HURA IMDX
HURA vs IMDX: by the numbers
- •HURA is the larger company ($120M vs $117M market cap).
- •Both run net losses; HURA's is the smaller (0.00% vs -2955.63% net margin).
Metrics side by side
Valuation
| Metric | HURA | IMDX |
|---|---|---|
| P/S ratio | N/A | 70.19 |
| P/B ratio | 6.57 | N/A |
Profitability
| Metric | HURA | IMDX |
|---|---|---|
| Gross margin | 0.00% | 11.17% |
| Operating margin | 0.00% | -754.08% |
| Net margin | 0.00% | -2955.63% |
| ROE | -165.57% | N/A |
| ROIC | -137.40% | -223.06% |
Growth (annualized)
| Metric | HURA | IMDX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 27.24% |
| Total return CAGR (5Y) | -45.49% | -44.39% |
Frequently asked
- How have HURA and IMDX total returns compared?
- Over the past 10 years, HURA delivered -52.09% and IMDX delivered -29.11% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
TuHURA Biosciences ROEInsight Molecular Diagnostics ROETuHURA Biosciences operating marginInsight Molecular Diagnostics operating marginTuHURA Biosciences revenue growthInsight Molecular Diagnostics revenue growthTuHURA Biosciences free cash flowInsight Molecular Diagnostics free cash flow
TuHURA Biosciences & Insight Molecular Diagnostics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.